Page 38 - ARNM-2-1

Advances in Radiotherapy
& Nuclear Medicine 99m Tc-DOX in multidrug resistance studies

References methylenedioxypterocarpan and derivatives: Cytotoxic
effect on human leukemia cell lines. Eur J Med Chem.
1. Dickey JS, Rao VA. Current and proposed biomarkers 2009;44(2):920-925.
of anthracycline cardiotoxicity in cancer: Emerging
opportunities in oxidative damage and autophagy. Curr Mol doi: 10.1016/j.ejmech.2008.01.027
Med. 2012;12(6):763-771. 11. Salustiano EJS, Netto CD, Fernandes RF, et al. Comparison of
doi: 10.2174/156652412800792561 the cytotoxic effect of lapachol, α-lapachone and pentacyclic
1,4-naphthoquinones on human leukemic cells. Invest New
2. Speth PA, van Hoesel QG, Haanen C. Clinical
pharmacokinetics of doxorubicin. Clin Pharmacokinet. Drugs. 2010;28(2):139-144.
1988;15(1):15-31. doi: 10.1007/s10637-009-9231-y
doi: 10.2165/00003088-198815010-00002 12. Votto APS, Domingues BS, Souza MMD, et al. Toxicity
3. Alkreathy HM, Damanhouri ZA, Ahmed N, Slevin M, mechanisms of onion (Allium cepa) extracts and compounds
Osman AMM. Mechanisms of cardioprotective effect of aged in multidrug resistant erythroleukemic cell line. Water.
garlic extract against doxorubicin-induced cardiotoxicity. 2010;43:429-437.
Integr Cancer Ther. 2012;11(4):364-370. 13. Wagner-Souza K, Echevarria-Lima J, Rodrigues LAP,
doi: 10.1177/1534735411426726 Reis M, Rumjanek VM. Resistance to thapsigargin-induced
intracellular calcium mobilization in a multidrug resistant
4. Rumjanek VM, Trindade GS, Wagner-Souza K, et al. tumour cell line. Mol Cell Biochem. 2003;252(1-2):109-116.
Multidrug resistance in tumour cells: Characterisation of
the multidrug resistant cell line K562-Lucena 1. An Acad doi: 10.1023/a:1025586225941
Bras Ciênc. 2001;73(1):57-69. 14. Brock I, Hipfner DR, Nielsen BS, et al. Sequential
doi: 10.1590/s0001-37652001000100007 coexpression of the multidrug resistance genes MRP and
mdr1 and their products in VP-16 (etoposide)-selected H69
5. Bernardo AA, Pinto-Silva FE, Persechini PM, et al. Effect small cell lung cancer cells. Cancer Res. 1995;55(3):459-462.
of extracellular ATP on the human leukaemic cell line
K562 and its multidrug counterpart. Mol Cell Biochem. 15. Liu Z, Stevenson GD, Barrett HH, et al. Imaging recognition
2006;289(1-2):111-124. of inhibition of multidrug resistance in human breast cancer
xenografts using 99mTc-labeled sestamibi and tetrofosmin.
doi: 10.1007/s11010-006-9154-2
Nucl Med Biol. 2005;32(6):573-583.
6. de Souza Votto AP, Renon VP, Yunes JS, et al. Sensitivity to
microcystins: A comparative study in human cell lines with doi: 10.1016/j.nucmedbio.2005.04.014
and without multidrug resistance phenotype. Cell Biol Int. 16. Tanaka PY, Calore EE. P-glycoprotein expression in non-
2007;31(11):1359-1366. Hodgkin’s lymphomas of human immunodeficiency virus
doi: 10.1016/j.cellbi.2007.05.010 infected patients. Pathol Res Pract. 2007;203(1):1-7.
7. Leite D, Kassuya C, Mazzuco T, et al. The cytotoxic effect doi: 10.1016/j.prp.2006.09.004
and the multidrug resistance reversing action of lignans 17. Crow MJ, Grant G, Provenzale JM, Wax A. Molecular
from Phyllanthus amarus. Planta Med. 2006;72(15): imaging and quantitative measurement of epidermal
1353-1358. growth factor receptor expression in live cancer cells using
doi: 10.1055/s-2006-951708 immunolabeled gold nanoparticles. Am J Roentgenol.
2009;192(4):1021-1028.
8. Maia RC, Silva EA, Harab RC, Lucena M, Pires V,
Rumjanek VM. Sensitivity of vincristine-sensitive K562 and doi: 10.2214/AJR.07.3535
vincristine-resistant K562-Lucena 1 cells to anthracyclines 18. Dizdarevic S, Peters AM. Imaging of multidrug resistance in
and reversal of multidrug resistance. Braz J Med Biol Res. cancer. Cancer Imaging. 2011;11(1):1-8.
1996;29(4):467-472.
doi: 10.1102/1470-7330.2011.0001
9. Maia RC, Vasconcelos FC, de Sá Bacelar T, et al. LQB-
118, a pterocarpanquinone structurally related to lapachol 19. Chhikara BS, Mandal D, Parang K. Synthesis. Anticancer
[2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: activities, and cellular uptake studies of lipophilic derivatives
A novel class of agent with high apoptotic effect in chronic of doxorubicin succinate. J Med Chem. 2012;55(4):
myeloid leukemia cells. Invest New Drugs. 2011;29(6): 1500-1510.
1143-1155. doi: 10.1021/jm201653u
doi: 10.1007/s10637-010-9453-z 20. Lammers T, Storm G, Kiessling F. Nanomedicine
10. Netto CD, Santos ESJ, Castro CP, da Silva AJM, formulations for combination therapies. Nano Rev. 2010;
Rumjanek VM, Costa PRR. (±)-3,4-Dihydroxy-8,9- 1:1-3.

Volume 2 Issue 1 (2024) 7 https://doi.org/10.36922/arnm.2822